{
    "eid": "2-s2.0-85109378313",
    "title": "The endocannabinoidome in neuropsychiatry: Opportunities and potential risks",
    "cover-date": "2021-08-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "Affective disorders",
        "Bipolar disorder",
        "Depression",
        "Endocannabinoid receptors",
        "Neuro-immune",
        "Neurodegeneration",
        "Neuroscience",
        "Neurotoxicity",
        "Oxidative stress",
        "Psychiatry",
        "Schizophrenia"
    ],
    "authors": [
        "Gerwyn Morris",
        "Ken Walder",
        "Stefan Kloiber",
        "Paul Amminger",
        "Michael Berk",
        "Chiara C. Bortolasci",
        "Michael Maes",
        "Basant K. Puri",
        "Andre F. Carvalho"
    ],
    "citedby-count": 19,
    "ref-count": 574,
    "ref-list": [
        "Diverse TRPV1 responses to cannabinoids",
        "An update on PPAR activation by cannabinoids",
        "An introduction to the endocannabinoid system: from the early to the latest concepts",
        "International union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB11111 and CB22222",
        "The endocannabinoidome as a substrate for noneuphoric phytocannabinoid action and gut microbiome dysfunction in neuropsychiatric disorders",
        "Rapid and concomitant gut microbiota and endocannabinoidome response to diet-induced obesity in mice",
        "Cannabinoids and the expanded endocannabinoid system in neurological disorders",
        "Beyond the canonical endocannabinoid system. a screening of PPAR ligands as FAAH Inhibitors",
        "Cannabinoid ligands targeting TRP channels",
        "The novel cannabinoid receptor GPR55 mediates anxiolytic-like effects in the medial orbital cortex of mice with acute stress",
        "Endocannabinoids in synaptic plasticity and neuroprotection",
        "Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction",
        "Cannabinoid receptors couple to NMDA receptors to reduce the production of NO and the mobilization of zinc induced by glutamate",
        "Endocannabinoids and heterogeneity of glial cells in brain function",
        "Astrocytes in endocannabinoid signalling",
        "Endocannabinoids modulate human blood-brain barrier permeability in vitro",
        "Cannabinoids, blood-brain barrier, and brain disposition",
        "Endocannabinoid signalling in reward and addiction",
        "Role of the endocannabinoid system in drug addiction",
        "The endocannabinoid system in pain and inflammation: Its relevance to rheumatic disease",
        "The role of the endocannabinoid system in pain",
        "Endocannabinoid signaling regulates sleep stability",
        "Endocannabinoid signaling and the hypothalamic-pituitary-adrenal axis",
        "Pharmacological augmentation of endocannabinoid signaling reduces the neuroendocrine response to stress",
        "The endocannabinoid system: directing eating behavior and macronutrient metabolism",
        "Role of the endocannabinoid system in the neuroendocrine responses to inflammation",
        "Endocannabinoid system in hepatic glucose metabolism, fatty liver disease, and cirrhosis",
        "The role of the pancreatic endocannabinoid system in glucose metabolism",
        "The role of the endocannabinoid system in lipogenesis and fatty acid metabolism",
        "Endocannabinoids in the gut",
        "The role of the endocannabinoid system in the brain-gut axis",
        "The endocannabinoid system and heart disease: the role of cannabinoid receptor type 2",
        "Targeting cannabinoid receptor CB(2) in cardiovascular disorders: promises and controversies",
        "The activated endocannabinoid system in atherosclerosis: driving force or protective mechanism?",
        "Endocannabinoid system in the airways",
        "Endocannabinoid system and the kidneys: from renal physiology to injury and disease",
        "The endocannabinoid system: pivotal orchestrator of obesity and metabolic disease",
        "Cannabinoids for treating cardiovascular disorders: putting together a complex puzzle",
        "Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes",
        "The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings",
        "Members of the endocannabinoid system are distinctly regulated in inflammatory bowel disease and colorectal cancer",
        "Endocannabinoid system alterations in Alzheimer's disease: a systematic review of human studies",
        "Distinctive evidence involved in the role of endocannabinoid signalling in Parkinson's disease: a perspective on associated therapeutic interventions",
        "Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies",
        "A critical review of the role of the cannabinoid compounds \u03949-tetrahydrocannabinol (\u03949-THC) and cannabidiol (CBD) and their combination in multiple sclerosis treatment",
        "Role of the endocannabinoid system in the pathophysiology of schizophrenia: implications for pharmacological intervention",
        "Cannabinoid type-1 receptor signaling in central serotonergic neurons regulates anxiety-like behavior and sociability",
        "Cannabinoid regulation of fear and anxiety: an update",
        "Endocannabinoid system: role in depression, reward and pain control (Review)",
        "The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications",
        "Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors",
        "Neuroprogression in schizophrenia: pathways underpinning clinical staging and therapeutic corollaries",
        "Cannabinoid receptor CNR1 expression and DNA methylation in human prefrontal cortex, hippocampus and caudate in brain development and schizophrenia",
        "Links between central CB1-receptor availability and peripheral endocannabinoids in patients with first episode psychosis",
        "Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR",
        "Reciprocal alterations in cortical cannabinoid receptor 1 binding relative to protein immunoreactivity and transcript levels in schizophrenia",
        "Positron emission tomography studies on cannabinoid receptor type 1 in schizophrenia",
        "Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia",
        "In vivo availability of cannabinoid 1 receptor levels in patients with first-episode psychosis",
        "Reduced brain cannabinoid receptor availability in schizophrenia",
        "Association between cannabinoid 1 receptor availability and glutamate levels in healthy controls and drug-free patients with first episode psychosis: a multi-modal PET and 1H-MRS study",
        "Chapter eight - the endocannabinoid system and anxiety",
        "Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression",
        "The CNR1 gene in depression and schizophrenia\u2014Is there an association with early improvement and response?",
        "Cannabinoid receptor 1 (CNR1) gene: impact on antidepressant treatment response and emotion processing in major depression",
        "Endocannabinoid system components as potential biomarkers in psychiatry",
        "Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression",
        "Expression pattern of the cannabinoid receptor genes in the frontal cortex of mood disorder patients and mice selectively bred for high and low fear",
        "The association of endocannabinoid receptor genes (CNR1 and CNR2) polymorphisms with depression: a meta-analysis",
        "Endocannabinoid system in psychotic and mood disorders, a review of human studies",
        "Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential",
        "Measuring disturbance of the endocannabinoid system in psychosis: a systematic review and meta-analysis",
        "Peripheral endogenous cannabinoid levels are increased in schizophrenia patients evaluated in a psychiatric emergency setting",
        "Interactions between anandamide and corticotropin-releasing factor signaling modulate human amygdala function and risk for anxiety disorders: an imaging genetics strategy for modeling molecular interactions",
        "Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder",
        "Serum Endocannabinoid Content Is Altered In Females With Depressive Disorders: A Preliminary Report",
        "Schizophrenia and depression, two poles of endocannabinoid system deregulation",
        "Plasma concentrations of endocannabinoids and congeners in a primary care sample of depressed patients: influence of biological variables, severity and antidepressant medication",
        "Serum endocannabinoid and mood changes after exercise in major depressive disorder",
        "Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective study",
        "Bipolar disorder and the endocannabinoid system",
        "Overcoming the psychiatric side effects of the cannabinoid CB1 receptor antagonists: current approaches for therapeutics development",
        "Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression",
        "CB1 allosteric modulators and their therapeutic potential in CNS disorders",
        "Targeting cannabinoid receptors: current status and prospects of natural products",
        "Brain cannabinoid receptor 2: expression, function and modulation",
        "Mechanisms of cannabinoid CB2 receptor-mediated reduction of dopamine neuronal excitability in mouse ventral tegmental area",
        "Are CB2 receptors a new target for schizophrenia treatment?",
        "CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity",
        "Functional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depression",
        "Distinct roles of neuronal and microglial CB2 cannabinoid receptors in the mouse hippocampus",
        "A central move for CB2 receptors",
        "Cannabinoid type 2 receptors mediate a cell type-specific plasticity in the hippocampus",
        "Cannabinoid type 2 receptors inhibit GABAA receptor-mediated currents in cerebellar Purkinje cells of juvenile mice",
        "Cannabinoid CB2 receptors are expressed in glutamate neurons in the red nucleus and functionally modulate motor behavior in mice",
        "CB\u2082 cannabinoid receptors inhibit synaptic transmission when expressed in cultured autaptic neurons",
        "Presynaptic cannabinoid CB2 receptors modulate [3H]-Glutamate release at subthalamo-nigral terminals of the rat",
        "CB(1) receptor signaling in the brain: extracting specificity from ubiquity",
        "Postsynaptic origin of CB1-dependent tonic inhibition of GABA release at cholecystokinin-positive basket cell to pyramidal cell synapses in the CA1 region of the rat hippocampus",
        "Role of CB2 cannabinoid receptors in the rewarding, reinforcing, and physical effects of nicotine",
        "Cannabinoid CB1 and CB2 receptors, and monoacylglycerol lipase gene expression alterations in the basal ganglia of patients with Parkinson's disease",
        "Selective CB2 receptor agonism protects central neurons from remote axotomy-induced apoptosis through the PI3K/Akt Pathway",
        "An overview of the cannabinoid type 2 receptor system and its therapeutic potential",
        "The endocannabinoid system and neuropathic pain",
        "Compensatory activation of cannabinoid CB2 receptor inhibition of GABA release in the rostral ventromedial medulla in inflammatory pain",
        "Prevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system",
        "Cannabinoid receptor type 2 activation induces a microglial anti-inflammatory phenotype and reduces migration via MKP induction and ERK dephosphorylation",
        "Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system",
        "CB1 receptor activation induces intracellular Ca2+mobilization and 2-arachidonoylglycerol release in rodent spinal cord astrocytes",
        "The diacylglycerol lipases: structure, regulation and roles in and beyond endocannabinoid signalling",
        "2-Arachidonoylglycerol: a signaling lipid with manifold actions in the brain",
        "Complementary synaptic distribution of enzymes responsible for synthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in the human hippocampus",
        "A key role for diacylglycerol lipase-alpha in metabotropic glutamate receptor-dependent endocannabinoid mobilization",
        "CaMKII regulates diacylglycerol lipase-\u03b1 and striatal endocannabinoid signaling",
        "Mechanism of activation and inactivation of Gq/phospholipase C-\u03b2 signaling nodes",
        "Gq-coupled receptors in autoimmunity",
        "Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS",
        "ATP induces a rapid and pronounced increase in 2-arachidonoylglycerol production by astrocytes, a response limited by monoacylglycerol lipase",
        "Astrocytes in culture produce anandamide and other acylethanolamides",
        "Receptor-dependent formation of endogenous cannabinoids in cortical neurons",
        "Functional lipidomics. Calcium-independent activation of endocannabinoid/endovanilloid lipid signalling in sensory neurons by protein kinases C and A and thrombin",
        "Bovine brain diacylglycerol lipase: substrate specificity and activation by cyclic AMP-dependent protein kinase",
        "Can phosphorylation and dephosphorylation of rod outer segment membranes affect phosphatidate phosphohydrolase and diacylglycerol lipase activities?",
        "Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release",
        "Neuronal calcium and cAMP cross-talk mediated by cannabinoid CB(1) receptor and EF-hand calcium sensor interactions",
        "Astrocyte glycogenolysis is triggered by store-operated calcium entry and provides metabolic energy for cellular calcium homeostasis",
        "Store-operated Ca2+-entry and adenylyl cyclase",
        "Phospholipases A\u2081",
        "The endocannabinoid system and its modulation by phytocannabinoids",
        "Metabolism of endocannabinoids and related N-acylethanolamines: canonical and alternative pathways",
        "Phosphoinositide-specific phospholipase C in health and disease",
        "2-Arachidonoyl-sn-glycero-3-phosphate, an arachidonic acid-containing lysophosphatidic acid: occurrence and rapid enzymatic conversion to 2-arachidonoyl-sn-glycerol, a cannabinoid receptor ligand, in rat brain",
        "Critical enzymes involved in endocannabinoid metabolism",
        "Endocannabinoids generated by Ca2+or by metabotropic glutamate receptors appear to arise from different pools of diacylglycerol lipase",
        "A review on the monoacylglycerol lipase: at the interface between fat and endocannabinoid signalling",
        "Monoglyceride lipase: structure and inhibitors",
        "COX-2 and fatty acid amide hydrolase can regulate the time course of depolarization-induced suppression of excitation",
        "COX-2 oxidative metabolite of endocannabinoid 2-AG enhances excitatory glutamatergic synaptic transmission and induces neurotoxicity",
        "Prostaglandin E2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NFkappaB activity",
        "Structural determinants for calcium mobilization by prostaglandin E2 and prostaglandin F2alpha glyceryl esters in RAW 264.7 cells and H1819 cells",
        "Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides",
        "Selective oxygenation of the endocannabinoid 2-arachidonylglycerol by leukocyte-type 12-lipoxygenase",
        "A novel acylglycerol kinase that produces lysophosphatidic acid modulates cross talk with EGFR in prostate cancer cells",
        "A calcium-dependent acyltransferase that produces N-acyl phosphatidylethanolamines",
        "Phosphatidylserine-stimulated production of N-acyl-phosphatidylethanolamines by Ca(2+)-dependent N-acyltransferase",
        "Enzymatic formation of anandamide",
        "New players in the fatty acyl ethanolamide metabolism",
        "Intracellular Ca2+-dependent formation of N-acyl-phosphatidylethanolamines by human cytosolic phospholipase A2\u03b5",
        "The role of intracellular anionic phospholipids in the production of N-acyl-phosphatidylethanolamines by cytosolic phospholipase A2\u025b",
        "Characterization of N-acyl phosphatidylethanolamine-specific phospholipase-D isoforms in the nematode caenorhabditis elegans",
        "The role of sex steroid hormones, cytokines and the endocannabinoid system in female fertility",
        "Functional analysis of the purified anandamide-generating phospholipase D as a member of the metallo-\u03b2-lactamase family",
        "Metabolism of the endocannabinoid anandamide: open questions after 25 years",
        "Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase D",
        "Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdown",
        "Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway",
        "A biosynthetic pathway for anandamide",
        "Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-kappaB independently of platelet-activating factor",
        "Biosynthesis and fate of endocannabinoids",
        "A personal retrospective: elevating anandamide (AEA) by targeting fatty acid amide hydrolase (FAAH) and the fatty acid binding proteins (FABPs)",
        "A perspective review on fatty acid amide hydrolase (FAAH) inhibitors as potential therapeutic agents",
        "Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications",
        "Metabolism of anandamide into eoxamides by 15-lipoxygenase-1 and glutathione transferases",
        "Endocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: cross-talk between the eicosanoid and endocannabinoid signaling pathways",
        "Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation",
        "Endocannabinoids and their oxygenation by cyclo-oxygenases, lipoxygenases and other oxygenases",
        "Control of synaptic function by endocannabinoid-mediated retrograde signaling",
        "The role of TRPV1 receptors in the antinociceptive effect of anandamide at spinal level",
        "Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid/endovanilloid system",
        "Direct anandamide activation of TRPV1 produces divergent calcium and current responses",
        "Involvement of the peroxisome proliferator-activated receptor (PPAR) alpha in vascular response of endocannabinoids in the bovine ophthalmic artery",
        "The endocannabinoids anandamide and virodhamine modulate the activity of the candidate cannabinoid receptor GPR55",
        "The orphan receptor GPR55 is a novel cannabinoid receptor",
        "Advances in the physiology of GPR55 in the central nervous system",
        "Endocannabinoids and related N-acylethanolamines: biological activities and metabolism",
        "Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents",
        "A systematic review of the effects of oleoylethanolamide, a high-affinity endogenous ligand of PPAR-\u03b1, on the management and prevention of obesity",
        "Oleoylethanolamide, an endogenous PPAR-\u03b1 agonist, lowers body weight and hyperlipidemia in obese rats",
        "Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha",
        "Palmitoylethanolamide modulates GPR55 receptor signaling in the ventral hippocampus to regulate mesolimbic dopamine activity, social interaction, and memory processing",
        "Palmitoylethanolamide in CNS health and disease",
        "The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations",
        "Modulation of the endocannabinoid system as a potential anticancer strategy",
        "Pharmacological characterization of GPR55, a putative cannabinoid receptor",
        "Cannabinoid receptor-related orphan G protein-coupled receptors",
        "The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)",
        "Optimized synthesis and characterization of N-acylethanolamines and O-acylethanolamines, important family of lipid-signalling molecules",
        "N-Arachidonoyl dopamine: a novel endocannabinoid and endovanilloid with widespread physiological and pharmacological activities",
        "Endocannabinoids and endocannabinoid-related mediators: targets, metabolism and role in neurological disorders",
        "Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor",
        "N-acyl dopamines induce apoptosis in PC12 cell line via the GPR55 receptor activation",
        "Fatty acid amidohydrolase in human neocortex\u2014Activity in epileptic and non-epileptic brain tissue and inhibition by putative endocannabinoids",
        "TRPV1 acts as a synaptic protein and regulates vesicle recycling",
        "Cannabinoid CB1 and CB2 receptor-mediated arrestin translocation: species, subtype, and agonist-dependence",
        "CB1 receptors down-regulate a cAMP/Epac2/PLC pathway to silence the nerve terminals of cerebellar granule cells",
        "Interactions of the \u03b1-subunits of heterotrimeric G-proteins with GPCRs, effectors and RGS proteins: a critical review and analysis of interacting surfaces, conformational shifts, structural diversity and electrostatic potentials",
        "Gi/o-protein coupled receptors in the aging brain",
        "Double suppression of the G\u03b1 protein activity by RGS proteins",
        "Recent progress in understanding the conformational mechanism of heterotrimeric G protein activation",
        "Specific inhibition of GPCR-independent G protein signaling by a rationally engineered protein",
        "Heterotrimeric G protein signaling via GIV/Girdin: breaking the rules of engagement, space, and time",
        "Heterotrimeric g proteins: insights into the neurobiology of mood disorders",
        "Structural features of the G-protein/GPCR interactions",
        "Structure, function, pharmacology, and therapeutic potential of the G protein, G\u03b1/q,11",
        "G\u03b112/13 signaling in metabolic diseases",
        "Proteins as therapeutic targets in drug discovery",
        "G\u03b1(i/o)-coupled receptor-mediated sensitization of adenylyl cyclase: 40 years later",
        "Sensitization of adenylate cyclase by G\u03b1i/o-coupled receptors",
        "CB(1) cannabinoid receptors and their associated proteins",
        "Structural mechanism underlying G protein family-specific regulation of G protein-gated inwardly rectifying potassium channel",
        "G\u03b1(s) signalling of the CB(1) receptor and the influence of receptor number",
        "The G protein g\u03b1s acts as a tumor suppressor in sonic hedgehog signaling-driven tumorigenesis",
        "Activation of phospholipase C by the alpha subunits of the Gq and G11 proteins in transfected Cos-7 cells",
        "Galpha(q) and phospholipase C-beta: turn on, turn off, and do it fast",
        "Structural insights from recent CB1 X-ray crystal structures",
        "Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor",
        "Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gslinkage to the CB1 receptor",
        "Cannabinoid agonists stimulate [3H]GABA release in the globus pallidus of the rat when Gi protein-receptor coupling is restricted: role of dopamine D2 receptors",
        "Cannabinoid CB1 receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues",
        "The stimulatory effect of cannabinoids on calcium uptake is mediated by Gsssss GTP-binding proteins and cAMP formation",
        "Cannabinoid CB(1) and CB(2) receptor signaling and bias",
        "Biased agonism of three different cannabinoid receptor agonists in mouse brain cortex",
        "The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins",
        "G\u03b2\u03b3 pathways in cell polarity and migration linked to oncogenic GPCR signaling: potential relevance in tumor microenvironment",
        "G\u03b2\u03b3 subunits\u2014Different spaces, different faces",
        "Targeting G protein-coupled receptor signaling at the G protein level with a selective nanobody inhibitor",
        "Regulation of receptor trafficking by GRKs and arrestins",
        "Structure of active \u03b2-arrestin-1 bound to a G-protein-coupled receptor phosphopeptide",
        "Identification of phosphorylation codes for arrestin recruitment by G protein-coupled receptors",
        "Distinct phosphorylation sites on the \u03b2(2)-adrenergic receptor establish a barcode that encodes differential functions of \u03b2-arrestin",
        "Mechanisms of biased \u03b2-arrestin-mediated signaling downstream from the cannabinoid 1 receptor",
        "GPCR signaling regulation: the role of GRKs and arrestins",
        "G-protein-coupled receptor kinases in inflammation and disease",
        "Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser",
        "Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signaling",
        "Visualization of arrestin recruitment by a G-protein-coupled receptor",
        "The multiple waves of cannabinoid 1 receptor signaling",
        "Signalling bias in new drug discovery: detection, quantification and therapeutic impact",
        "Distinct roles of \u03b2-arrestin 1 and \u03b2-arrestin 2 in ORG27569-induced biased signaling and internalization of the cannabinoid receptor 1 (CB1)",
        "Emerging functional divergence of \u03b2-arrestin isoforms in GPCR function",
        "GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling",
        "The \u03b2-arrestins: multifunctional regulators of G protein-coupled receptors",
        "Arrestins as regulators of kinases and phosphatases",
        "Antagonism of dopamine receptor 2 long affects cannabinoid receptor 1 signaling in a cell culture model of striatal medium spiny projection neurons",
        "Cannabinoid receptors: an update on cell signaling, pathophysiological roles and therapeutic opportunities in neurological, cardiovascular, and inflammatory diseases",
        "Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system",
        "Receptor heteromerization expands the repertoire of cannabinoid signaling in rodent neurons",
        "Heteromultimerization of Cannabinoid CB1receptor and orexin OX1receptor generates a unique complex in which both protomers are regulated by orexin A",
        "Targeting cutaneous cannabinoid signaling in inflammation - a \u201chigh\u201d-way to heal?",
        "Structure of an allosteric modulator bound to the CB1 cannabinoid receptor",
        "Enantiospecific allosteric modulation of cannabinoid 1 receptor",
        "Positive allosteric modulation of CB1 cannabinoid receptor signaling enhances morphine antinociception and attenuates morphine tolerance without enhancing morphine- induced dependence or reward",
        "Endocannabinoid-mediated control of synaptic transmission",
        "Distribution of cannabinoid receptors in the central and peripheral nervous system",
        "Cannabinoid receptors in the central nervous system: their signaling and roles in disease",
        "Endocannabinoid signaling at the periphery: 50 years after THC",
        "Characterisation of cannabinoid 1 receptor expression in the perikarya, and peripheral and spinal processes of primary sensory neurons",
        "Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism",
        "The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling",
        "Modulatory effects of cannabinoids on brain neurotransmission",
        "Endocannabinoid modulation of dopamine neurotransmission",
        "Endocannabinoid signaling and synaptic function",
        "Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons",
        "Mechanisms of long-term plasticity of hippocampal GABAergic synapses",
        "Endogenous cannabinoid release within prefrontal-limbic pathways affects memory consolidation of emotional training",
        "Cannabinoid CB1 receptor-dependent long-term depression in autaptic excitatory neurons",
        "Endocannabinoid system: the direct and indirect involvement in the memory and learning processes-a short review",
        "Emerging mechanisms underlying dynamics of GABAergic synapses",
        "The role of 5-HT receptors in depression",
        "Lack of CB1 receptor activity impairs serotonergic negative feedback",
        "Endocannabinoid regulation of reward and reinforcement through interaction with dopamine and endogenous opioid signaling",
        "Sex-specific tonic 2-arachidonoylglycerol signaling at inhibitory inputs onto dopamine neurons of lister hooded rats",
        "Cocaine-induced endocannabinoid mobilization in the ventral tegmental area",
        "Cannabinoid CB1 and dopamine D1 receptors partnership in the modulation of emotional neural processing",
        "Role of the endocannabinoid system in diabetes and diabetic complications",
        "The endocannabinoid system in brain reward processes",
        "New horizons on the role of cannabinoid CB1 receptors in palatable food intake, obesity and related dysmetabolism",
        "Hedonic eating and the \u201cdelicious circle\u201d: from lipid-derived mediators to brain dopamine and back",
        "Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre-clinical and clinical studies",
        "Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation",
        "Dysregulation of cannabinoid CB1 receptor and associated signaling networks in brains of cocaine addicts and cocaine-treated rodents",
        "Reduced cannabinoid CB1 receptor binding in alcohol dependence measured with positron emission tomography",
        "Comorbid mental disorders in substance users from a single catchment area - a clinical study",
        "Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders",
        "Inhibition of hippocampal acetylcholine release by cannabinoids: reversal by SR 141716A",
        "Cannabinoid and cholinergic systems interact during performance of a short-term memory task in the rat",
        "Peripheral and central CB1 cannabinoid receptors control stress-induced impairment of memory consolidation",
        "Presynaptic \u03b1\u2082-adrenoceptors control the inhibitory action of presynaptic CB\u2081 cannabinoid receptors on prefrontocortical norepinephrine release in the rat",
        "Endocannabinoids and stress",
        "Cannabinoids and glucocorticoids modulate emotional memory after stress",
        "Induced ketosis as a treatment for neuroprogressive disorders: food for thought?",
        "The role of microglia in neuroprogressive disorders: mechanisms and possible neurotherapeutic effects of induced ketosis",
        "Cyclic AMP is a key regulator of M1 to M2a phenotypic conversion of microglia in the presence of Th2 cytokines",
        "Why should neuroscientists worry about iron? The emerging role of ferroptosis in the pathophysiology of neuroprogressive diseases",
        "The role of the microbial metabolites including tryptophan catabolites and short chain fatty acids in the pathophysiology of immune-inflammatory and neuroimmune disease",
        "The neuro-immune pathophysiology of central and peripheral fatigue in systemic immune-inflammatory and neuro-immune diseases",
        "Nutritional ketosis as an intervention to relieve astrogliosis: possible therapeutic applications in the treatment of neurodegenerative and neuroprogressive disorders",
        "Astrocyte-neuron networks: a multilane highway of signaling for homeostatic brain function",
        "Astrocytes: role and functions in brain pathologies",
        "Astrocytes phagocytose adult hippocampal synapses for circuit homeostasis",
        "The anti-neuroinflammatory role of anthocyanins and their metabolites for the prevention and treatment of brain disorders",
        "Pharmacological targeting of microglial activation: new therapeutic approach",
        "CB1 cannabinoid receptors and on-demand defense against excitotoxicity",
        "Regulatory role of cannabinoid receptor 1 in stress-induced excitotoxicity and neuroinflammation",
        "The CB\u2081 cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathway",
        "A restricted population of CB1 cannabinoid receptors with neuroprotective activity",
        "Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1",
        "Endocannabinoids anandamide and 2-arachidonoylglycerol are substrates for human CYP2J2 epoxygenase",
        "Liu Q-s, Lichtman AH, Cravatt BF. Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system",
        "Endocannabinoid-mediated retrograde modulation of synaptic transmission",
        "Endocannabinoid-LTP mediated by CB1 and TRPV1 receptors encodes for limited occurrences of coincident activity in neocortex",
        "Endocannabinoid signaling as a synaptic circuit breaker in neurological disease",
        "Anandamide, cannabinoid type 1 receptor, and NMDA receptor activation mediate non-Hebbian presynaptically expressed long-term depression at the first central synapse for visceral afferent fibers",
        "TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus",
        "Postsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens",
        "Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum",
        "Leaky brain in neurological and psychiatric disorders: drivers and consequences",
        "Endocannabinoids mediate neuron-astrocyte communication",
        "Neuronal and glial localization of the cannabinoid-1 receptor in the superficial spinal dorsal horn of the rodent spinal cord",
        "Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas",
        "The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells",
        "Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling",
        "Functions of the CB1 and CB 2 receptors in neuroprotection at the level of the blood-brain barrier",
        "Endocannabinoids and endocannabinoid-like compounds modulate hypoxia-induced permeability in CaCo-2 cells via CB(1), TRPV1, and PPAR\u03b1",
        "Synaptic functions of endocannabinoid signaling in health and disease",
        "Bimodal control of fear-coping strategies by CB1 cannabinoid receptors",
        "Astroglial type-1 cannabinoid receptor (CB1): a new player in the tripartite synapse",
        "Rising stars: modulation of brain functions by astroglial type-1 cannabinoid receptors",
        "Endocannabinoids induce lateral long-term potentiation of transmitter release by stimulation of gliotransmission",
        "Astroglial CB1 receptors determine synaptic D-serine availability to enable recognition memory",
        "Astrocytic endocannabinoids mediate hippocampal transient heterosynaptic depression",
        "Endocannabinoids potentiate synaptic transmission through stimulation of astrocytes",
        "The NMDA receptor activation by d-serine and glycine is controlled by an astrocytic Phgdh-dependent serine shuttle",
        "Astrocytic regulation of glutamate transmission in schizophrenia",
        "Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD",
        "Neuron to astrocyte communication via cannabinoid receptors is necessary for sustained epileptiform activity in rat hippocampus",
        "The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells",
        "Overactive endocannabinoid signaling impairs apolipoprotein E-mediated clearance of triglyceride-rich lipoproteins",
        "Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice",
        "Endothelial dysfunction in neuroprogressive disorders-causes and suggested treatments",
        "The lancet psychiatry commission: a blueprint for protecting physical health in people with mental illness",
        "Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls",
        "Shared metabolic and immune-inflammatory, oxidative and nitrosative stress pathways in the metabolic syndrome and mood disorders",
        "Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning",
        "Adipocyte cannabinoid receptor CB1 regulates energy homeostasis and alternatively activated macrophages",
        "The case for peripheral CB1receptor blockade in the treatment of visceral obesity and its cardiometabolic complications",
        "The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders",
        "Peripheral cannabinoid 1 receptor blockade activates brown adipose tissue and diminishes dyslipidemia and obesity",
        "Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice",
        "Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasingde novosynthesis of long-chain ceramides",
        "Absence of cannabinoid 1 receptor in beta cells protects against high-fat/high-sugar diet-induced beta cell dysfunction and inflammation in murine islets",
        "Blockade of cannabinoid 1 receptor improves glucose responsiveness in pancreatic beta cells",
        "Cannabinoids, the heart of the matter",
        "Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy",
        "Blockade of CB1 cannabinoid receptor alters gut microbiota and attenuates inflammation and diet-induced obesity",
        "The role of microbiota and intestinal permeability in the pathophysiology of autoimmune and neuroimmune processes with an emphasis on inflammatory bowel disease type 1 diabetes and chronic fatigue syndrome",
        "Gut microbiota, bacterial translocation, and interactions with diet: pathophysiological links between major depressive disorder and non-communicable medical comorbidities",
        "Cannabinoids and the gastrointestinal tract",
        "Cannabinoid CB1 receptors inhibit gut-brain satiation signaling in diet-induced obesity",
        "The role of CB(1) in intestinal permeability and inflammation",
        "Characterization of drug resistance mediated via the suppression of apoptosis by Abelson protein tyrosine kinase",
        "Cannabinoid CB(2) receptors modulate ERK-1/2 kinase signalling and NO release in microglial cells stimulated with bacterial lipopolysaccharide",
        "The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling",
        "Role of the highly conserved Asp-Arg-Tyr motif in signal transduction of the CB2 cannabinoid receptor",
        "Effect of lipid rafts on Cb2 receptor signaling and 2-arachidonoyl-glycerol metabolism in human immune cells",
        "Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity",
        "Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors",
        "Activation of cannabinoid CB2 receptor negatively regulates IL-12p40 production in murine macrophages: role of IL-10 and ERK1/2 kinase signaling",
        "Activation of cannabinoid CB2 receptor\u2013mediated AMPK/CREB pathway reduces cerebral ischemic injury",
        "The second intracellular loop of the human cannabinoid CB2 receptor governs G protein coupling in coordination with the carboxyl terminal domain",
        "Cannabinoid receptor 2 (CB2) signals via G-alpha-s and induces IL-6 and IL-10 cytokine secretion in human primary leukocytes",
        "Differential activation of intracellular versus plasmalemmal CB2 cannabinoid receptors",
        "Beta-caryophyllene is a dietary cannabinoid",
        "Cannabinoid receptor type 1- and 2-mediated increase in cyclic AMP inhibits T cell receptor-triggered signaling",
        "Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation",
        "p38 MAPK is involved in CB2 receptor-induced apoptosis of human leukaemia cells",
        "The CB2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway",
        "Functional selectivity in CB22222 cannabinoid receptor signaling and regulation: implications for the therapeutic potential of CB22222 ligands",
        "Cannabinoid receptor 2 undergoes Rab5-mediated internalization and recycles via a Rab11-dependent pathway",
        "Mastering tricyclic ring systems for desirable functional cannabinoid activity",
        "Characterizing cannabinoid CB2 receptor ligands using DiscoveRx pathhunter beta-arrestin assay",
        "Cannabinoid receptor 2 signalling bias elicited by 2,4,6-trisubstituted 1,3,5-triazines",
        "Retromer stops beta-arrestin 1-mediated signaling from internalized cannabinoid 2 receptors",
        "Functional selectivity of CB2 cannabinoid receptor ligands at a canonical and noncanonical pathway",
        "Simultaneous activation of induced heterodimerization between CXCR4 chemokine receptor and cannabinoid receptor 2 (CB2) reveals a mechanism for regulation of tumor progression",
        "First in vivo evidence for a functional interaction between chemokine and cannabinoid systems in the brain",
        "The endocannabinoid system as a target in cancer diseases: are we there yet?",
        "Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain",
        "Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain",
        "Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain",
        "Depression-resistant endophenotype in mice overexpressing cannabinoid CB2 receptors",
        "Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice",
        "CB2 receptors in the brain: role in central immune function",
        "Cannabinoid receptor 2 signaling in neurodegenerative disorders: from pathogenesis to a promising therapeutic target",
        "Alterations in gene and protein expression of cannabinoid CB2 and GPR55 receptors in the dorsolateral prefrontal cortex of suicide victims",
        "Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference",
        "Is the cannabinoid CB(2) receptor a major regulator of the neuroinflammatory axis of the neurovascular unit in humans?",
        "CB2 receptor activation inhibits melanoma cell transmigration through the blood-brain barrier",
        "Mechanisms of cannabinoid CB(2) receptor-mediated reduction of dopamine neuronal excitability in mouse ventral tegmental area",
        "Regulatory role of the cannabinoid CB2 receptor in stress-induced neuroinflammation in mice",
        "Possible interaction between the ventral hippocampal cannabinoid CB2 and muscarinic acetylcholine receptors on the modulation of memory consolidation in mice",
        "Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations",
        "A cannabinoid receptor 2 agonist reduces blood-brain barrier damage via induction of MKP-1 after intracerebral hemorrhage in rats",
        "Signaling mechanisms of selective PPAR\u03b3 modulators in Alzheimer's disease",
        "Activation of cannabinoid CB2 receptor-mediated AMPK/CREB pathway reduces cerebral ischemic injury",
        "Cerebral hypoxia-ischemia and middle cerebral artery occlusion induce expression of the cannabinoid CB2 receptor in the brain",
        "Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer's disease",
        "CB2 receptor deletion on myeloid cells enhanced mechanical allodynia in a mouse model of neuropathic pain",
        "CB2 cannabinoid receptor agonists: pain relief without psychoactive effects?",
        "Microglial phenotypes and their relationship to the cannabinoid system: therapeutic implications for Parkinson's disease",
        "A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis",
        "Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains",
        "Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation",
        "Activation of CB(2) receptor system restores cognitive capacity and hippocampal Sox2 expression in a transgenic mouse model of Alzheimer's disease",
        "Activation of cannabinoid receptor 2 attenuates mechanical allodynia and neuroinflammatory responses in a chronic post-ischemic pain model of complex regional pain syndrome type I in rats",
        "Spinal cannabinoid receptor type 2 activation reduces hypersensitivity and spinal cord glial activation after paw incision",
        "Cannabinoid CB(2) receptor attenuates morphine-induced inflammatory responses in activated microglial cells",
        "Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide",
        "Inflammatory regulation by driving microglial M2 polarization: neuroprotective effects of cannabinoid receptor-2 activation in intracerebral hemorrhage",
        "Endocannabinoid signaling in microglial cells",
        "P2X7 receptors control 2-arachidonoylglycerol production by microglial cells",
        "Identification of a novel endocannabinoid-hydrolyzing enzyme expressed by microglial cells",
        "Microglia produce and hydrolyze palmitoylethanolamide",
        "Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease",
        "Activation of murine microglial N9 cells is attenuated through cannabinoid receptor CB2 signaling",
        "Brain CB\u2082 receptors: implications for neuropsychiatric disorders",
        "Endocannabinoids drive the acquisition of an alternative phenotype in microglia",
        "The endocannabinoid system as a window into microglial biology and its relationship to autism",
        "Endocannabinoid modulation of microglial phenotypes in neuropathology",
        "ERK/MAPK is essential for endogenous neuroprotection in SCN2.2 cells",
        "N-methyl-D-aspartate and TrkB receptors protect neurons against glutamate excitotoxicity through an extracellular signal-regulated kinase pathway",
        "ERK 1/2 signaling pathway is involved in nicotine-mediated neuroprotection in spinal cord neurons",
        "17\u03b2-Estradiol-mediated Neuroprotection and ERK Activation Require A Pertussis Toxin-sensitive Mechanism Involving GRK2 and \u03b2-Arrestin-1",
        "The role of PI3K/Akt and ERK in neurodegenerative disorders",
        "Mitogen-activated protein kinases in innate immunity",
        "The anti-neuroinflammatory activity of tectorigenin pretreatment via downregulated NF-\u03baB and ERK/JNK pathways in BV-2 microglial and microglia inactivation in mice with lipopolysaccharide",
        "ERK/MAP kinase activation is evident in activated microglia of the striatum and substantia nigra in an acute and chronically-induced mouse model of Parkinson's disease",
        "Complement receptor 3 mediates NADPH oxidase activation and dopaminergic neurodegeneration through a Src-Erk-dependent pathway",
        "Signaling pathways controlling microglia chemotaxis",
        "Dexmedetomidine inhibits neuroinflammation by altering microglial M1/M2 polarization through MAPK/ERK pathway",
        "Inhibition of the MEK/ERK pathway reduces microglial activation and interleukin-1-beta expression in spinal cord ischemia/reperfusion injury in rats",
        "Microglia mediated neuroinflammation: focus on PI3K modulation",
        "Heterotrimeric G protein-dependent WNT-5A signaling to ERK1/2 mediates distinct aspects of microglia proinflammatory transformation",
        "Pertussis toxin-sensitive heterotrimeric G(\u03b1i/o) proteins mediate WNT/\u03b2-catenin and WNT/ERK1/2 signaling in mouse primary microglia stimulated with purified WNT-3A",
        "G protein-coupled \u03b17 nicotinic receptor regulates signaling and TNF-\u03b1 release in microglia",
        "The interplay between cyclic AMP, MAPK, and NF-\u03baB pathways in response to proinflammatory signals in microglia",
        "Proinflammatory cytokine regulation of cyclic AMP-phosphodiesterase 4 signaling in microgliain vitroand following CNS injury",
        "Cyclic AMP: a selective modulator of NF-\u03baB action",
        "Mild traumatic brain injury produces neuron loss that can be rescued by modulating microglial activation using a CB2 receptor inverse agonist",
        "Regulation of AMPK activity by type 10 adenylyl cyclase: contribution to the mitochondrial biology, cellular redox and energy homeostasis",
        "Regulation of AMP-activated protein kinase by cAMP in adipocytes: roles for phosphodiesterases, protein kinase B, protein kinase A, epac and lipolysis",
        "Adenosine and cAMP are potent inhibitors of the NF-kappa B pathway downstream of immunoreceptors",
        "The role of the transcription factor CREB in immune function",
        "Posttraumatic stress disorder in critical illness survivors: a metaanalysis",
        "Anti-Neuroinflammatory Effects Of Fucoxanthin Via Inhibition Of Akt/NF-\u03baB and MAPKs/AP-1 Pathways And Activation of PKA/CREB Pathway In Lipopolysaccharide-activated BV-2 Microglial Cells",
        "Redox regulation of NF-kappaB p50 and M1 polarization in microglia",
        "Modulation of Microglia Polarization Through Silencing of NF-\u03baB p65 by Functionalized Curdlan Nanoparticle-mediated RNAi",
        "Different Approaches To Modulation Of Microglia Phenotypes After Spinal Cord Injury",
        "Treatment in vitro with PPAR\u03b1 and PPAR\u03b3 ligands drives M1-to-M2 polarization of macrophages from T. cruzi-infected mice",
        "Immunoregulation of microglial polarization: an unrecognized physiological function of \u03b1-synuclein",
        "Schisantherin A attenuates neuroinflammation in activated microglia: role of Nrf2 activation through ERK phosphorylation",
        "Activation of Nrf2 pathway contributes to neuroprotection by the dietary flavonoid tiliroside",
        "Therapeutics potentiating microglial p21-Nrf2 axis can rescue neurodegeneration caused by neuroinflammation",
        "Up-regulation of IL-4 production by the activated cAMP/cAMP-dependent protein kinase (protein kinase A) pathway in CD3/CD28-stimulated naive T cells",
        "Unique, intersecting, and overlapping roles of C/EBP \u03b2 and CREB in cells of the innate immune system",
        "Both classic Gs-cAMP/PKA/CREB and alternative Gs-cAMP/PKA/p38\u03b2/CREB signal pathways mediate exenatide-stimulated expression of M2 microglial markers",
        "Interleukin 4 modulates microglia homeostasis and attenuates the early slowly progressive phase of amyotrophic lateral sclerosis",
        "Balancing the immune response in the brain: IL-10 and its regulation",
        "Neuroinflammation and M2 microglia: the good, the bad, and the inflamed",
        "IL-4 switches microglia/macrophage M1/M2 polarization and alleviates neurological damage by modulating the JAK1/STAT6 pathway following ICH",
        "How protein kinase A activates canonical tyrosine kinase signaling pathways to promote granulosa cell differentiation",
        "A cAMP-activated pathway, including PKA and PI3K, regulates neuronal differentiation",
        "Modulators of microglia activation and polarization in ischemic stroke (Review)",
        "How to reprogram microglia toward beneficial functions",
        "DHEA inhibits acute microglia-mediated inflammation through activation of the TrkA-Akt1/2-CREB-Jmjd3 pathway",
        "BDNF reverses aging-related microglial activation",
        "Loss of microglia and impaired brain-neurotrophic factor signaling pathway in a comorbid model of chronic pain and depression",
        "Neuroprotective effects of BHDPC, a novel neuroprotectant, on experimental stroke by modulating microglia polarization",
        "AMPK and SIRT1 activation contribute to inhibition of neuroinflammation by thymoquinone in BV2 microglia",
        "Amelioration of LPS-Induced Inflammation Response in Microglia by AMPK Activation",
        "Involvement of AMP-activated protein kinase in neuroinflammation and neurodegeneration in the adult and developing brain",
        "AMPK plays a dual role in regulation of CREB/BDNF pathway in mouse primary hippocampal cells",
        "Neurological enhancement effects of melatonin against brain injury-induced oxidative stress, neuroinflammation, and neurodegeneration via AMPK/CREB signaling",
        "Increased levels of cAMP by the calcium-dependent activation of soluble adenylyl cyclase in parkin-mutant fibroblasts",
        "Mitochondrial Ca2+ uptake induces cyclic AMP generation in the matrix and modulates organelle ATP levels",
        "Computational modeling reveals frequency modulation of calcium-cAMP/PKA pathway in dendritic spines",
        "Organization and Ca2+regulation of adenylyl cyclases in cAMP microdomains",
        "Physiological roles for G protein-regulated adenylyl cyclase isoforms: insights from knockout and overexpression studies",
        "Regulation by Ca2+-signaling pathways of adenylyl cyclases",
        "Chutes and Ladders: the search for protein kinases that act on AMPK",
        "AMP-activated protein kinase (AMPK) and energy-sensing in the brain",
        "Sevoflurane post-conditioning increases nuclear factor erythroid 2-related factor and haemoxygenase-1 expression via protein kinase C pathway in a rat model of transient global cerebral ischaemia",
        "Functional role of calcium signals for microglial function",
        "The Ca2+release-activated Ca2+current (ICRAC) mediates store-operated Ca2+entry in rat microglia",
        "Elevation of basal intracellular calcium as a central element in the activation of brain macrophages (microglia): suppression of receptor-evoked calcium signaling and control of release function",
        "The role of ion channels in microglial activation and proliferation \u2013 a complex interplay between ligand-gated ion channels, K+ channels, and intracellular Ca2+",
        "Microglial intracellular Ca2+signaling in synaptic development and its alterations in neurodevelopmental disorders",
        "Microglial calcium signal acts as a rapid sensor of single neuron damage in vivo",
        "In vivo imaging of microglial calcium signaling in brain inflammation and injury",
        "Structural insights into phospholipase C-\u03b2 function",
        "The phospholipase C isozymes and their regulation",
        "G protein \u03b2\u03b3 subunits directly interact with and activate phospholipase C\u03f5",
        "PLC\u03b5 mediated sustained signaling pathways",
        "Mammalian phospholipase C",
        "STIM- and orai-mediated calcium entry controls NF-\u03baB activity and function in lymphocytes",
        "Integration of kinase and calcium signaling at the level of chromatin underlies inducible gene activation in T cells",
        "The role of calcium, NF-\u03baB and NFAT in the regulation of CXCL8 and IL-6 expression in Jurkat T-cells",
        "A new approach for ratiometric in vivo calcium imaging of microglia",
        "Microglial calcium signaling is attuned to neuronal activity in awake mice",
        "Cannabinoid type 2 (CB2) receptors activation protects against oxidative stress and neuroinflammation associated dopaminergic neurodegeneration in rotenone model of Parkinson's disease",
        "Sulfenylation regulates 2-AG-mediated endocannabinoid signaling in brain neurons",
        "Monoglyceride lipase as a drug target: at the crossroads of arachidonic acid metabolism and endocannabinoid signaling",
        "A case series of the dynamics of lipid mediators in patients with sepsis",
        "The mRNA expression of fatty acid amide hydrolase in human whole blood correlates with sepsis",
        "Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes",
        "Inflammatory agents involved in septic miscarriage",
        "Peripheral blood mononuclear cells infiltration downregulates decidual FAAH activity in an LPS-induced embryo resorption model",
        "Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection",
        "Endocannabinoids alleviate proinflammatory conditions by modulating innate immune response in muller glia during inflammation",
        "Effect of anandamide uptake inhibition in the production of nitric oxide and in the release of cytokines in astrocyte cultures",
        "Anandamide enhances IL-10 production in activated microglia by targeting CB2receptors: roles of ERK1/2, JNK, and NF-\u03baB",
        "Anandamide inhibits IL-12p40 production by acting on the promoter repressor element GA-12: possible involvement of the COX-2 metabolite prostamide E2",
        "Augmentation of endogenous cannabinoid tone modulates lipopolysaccharide-induced alterations in circulating cytokine levels in rats",
        "The hypothalamic endocannabinoid system participates in the secretion of oxytocin and tumor necrosis factor-alpha induced by lipopolysaccharide",
        "The hypothermic response to bacterial lipopolysaccharide critically depends on brain CB1, but not CB2 or TRPV1, receptors",
        "Complement-mediated injury and protection of endothelium: lessons from atypical haemolytic uraemic syndrome",
        "Pharmacological inhibition of FAAH modulates TLR-induced neuroinflammation, but not sickness behaviour: an effect partially mediated by central TRPV1",
        "Endocannabinoids and traumatic brain injury",
        "CB1 cannabinoid receptors are involved in neuroprotection via NF-kappa B inhibition",
        "The endocannabinoid 2-AG protects the blood\u2013brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines",
        "Anandamide inhibits nuclear factor-kappaB activation through a cannabinoid receptor-independent pathway",
        "The modulatory effect of anandamide on nitroglycerin-induced sensitization in the trigeminal system of the rat",
        "Inhibition of microglial fatty acid amide hydrolase modulates LPS stimulated release of inflammatory mediators",
        "Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism",
        "Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors",
        "2-AG limits Theiler's virus induced acute neuroinflammation by modulating microglia and promoting MDSCs",
        "The endocannabinoid 2-AG enhances spontaneous remyelination by targeting microglia",
        "Regulation of blood\u2013brain barrier integrity by microglia in health and disease: a therapeutic opportunity",
        "T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases",
        "Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli",
        "Interferon-gamma is a critical modulator of CB(2) cannabinoid receptor signaling during neuropathic pain",
        "Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide",
        "Immunoregulation of experimental autoimmune encephalomyelitis by the selective CB1 receptor antagonist",
        "Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells",
        "Upregulation of cannabinoid receptor-1 and fibrotic activation of mouse hepatic stellate cells during Schistosoma J. infection: role of NADPH oxidase",
        "Pathophysiological Alterations Of Redox Signaling And Endocannabinoid System In Granulocytes And Plasma Of Psoriatic Patients",
        "Cannabinoid CB(2) Receptor Modulation By The Transcription Factor NRF2 is Specific In Microglial Cells",
        "Cannabis, the endocannabinoid System and Immunity-the journey from the Bedside To The Bench And Back",
        "Cannabinoids inhibit T-cells via cannabinoid receptor 2 in an in vitro assay for graft rejection, the mixed lymphocyte reaction",
        "Inhibition of orai1 Store-operated calcium channel prevents foam cell formation and atherosclerosis",
        "M1 macrophage Polarization Is Dependent on TRPC1-Mediated Calcium Entry",
        "Endocannabinoid system acts as a regulator of immune homeostasis in the gut",
        "Endocannabinoids and immune regulation",
        "Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses",
        "Endothelial CB1-receptors limit infarct size through NO formation in rat isolated hearts",
        "The cannabinoid receptor type 2 is time-dependently expressed during skeletal muscle wound healing in rats",
        "Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes",
        "Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation",
        "Activation of cannabinoid receptor 2 reduces inflammation in acute experimental pancreatitis via intra-acinar activation of p38 and MK2-dependent mechanisms",
        "CB2 receptor activation ameliorates the proinflammatory activity in acute lung injury induced by paraquat",
        "Activation of the cannabinoid receptor 2 increases renal perfusion",
        "CB2 receptors as new therapeutic targets for liver diseases",
        "Cannabinoid 2 receptor agonist improves systemic sensitivity to insulin in high-fat diet/streptozotocin-induced diabetic mice",
        "Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy",
        "Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseases",
        "New insights on atherosclerosis: a cross-talk between endocannabinoid systems with gut microbiota",
        "Role of cannabinoids in obesity",
        "Effect of simvastatin on Kruppel-like factor2, endothelial nitric oxide synthase and thrombomodulin expression in endothelial cells under shear stress",
        "Crystal structure of the human cannabinoid receptor CB2",
        "Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis",
        "A critical review of the cannabinoid receptor as a drug target for obesity management",
        "The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects"
    ],
    "affiliation": [
        {
            "affiliation-city": "Melbourne",
            "@id": "60118837",
            "affilname": "Centre for Youth Mental Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60118837",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Geelong",
            "@id": "60018805",
            "affilname": "Deakin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018805",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Plovdiv",
            "@id": "60031890",
            "affilname": "Medical University of Plovdiv",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031890",
            "affiliation-country": "Bulgaria"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Toronto",
            "@id": "60016849",
            "affilname": "University of Toronto",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016849",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Toronto",
            "@id": "60015765",
            "affilname": "Centre for Addiction and Mental Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015765",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Melbourne",
            "@id": "60003438",
            "affilname": "ORYGEN Youth Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60003438",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Cambridge",
            "@id": "126541977",
            "affilname": "Cambridge Advanced Research (C.A.R.)",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126541977",
            "affiliation-country": "United Kingdom"
        }
    ],
    "funding": [
        "Cooperative Research Centre",
        "Harry Windsor Foundation",
        "Lundbeck Merck",
        "Meat and Livestock Board",
        "Medical Research Futures Fund",
        "Simons Autism Foundation",
        "Stanley Medical Research Foundation",
        "NIH",
        "Pfizer",
        "University of Toronto Department of Psychiatry",
        "National Health and Medical Research Council",
        "Cancer Council of Victoria",
        "Servier"
    ]
}